UTAH MEDICAL PRODUCTS, INC. (UTMD) EBITDA
- 2026-06-30: Basis Reported; EBITDA (m); Operating income $2.65M; Depreciation and amortization (m).
- 2026-03-31: Basis Reported; EBITDA (m); Operating income $2.56M; Depreciation and amortization (m).
- 2025-09-30: Basis Reported; EBITDA (m); Operating income $2.61M; Depreciation and amortization (m).
- 2025-06-30: Basis Reported; EBITDA (m); Operating income $3.20M; Depreciation and amortization (m).
Historical EBITDA
EBITDA 3 month
| Date | Basis | EBITDA | Operating income | Depreciation and amortization | Revenue | EBITDA margin | Capital spending | Operating cash flow | Cost of products and services | Research and development | Selling, general and administration | Income tax expense / benefit |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | Reported | (m) | $2.65M | (m) | $8.53M | (m) | $134.00K* | $1.38M* | $3.77M | $154.00K | $1.96M | $600.00K |
| 2026-03-31 | Reported | (m) | $2.56M | (m) | $8.72M | (m) | $130.00K | $3.11M | $3.44M | $154.00K | $2.56M | $578.00K |
| 2025-09-30 | Reported | (m) | $2.61M | (m) | $9.81M | (m) | $27.00K* | $3.88M* | $4.21M | $167.00K | $2.83M | $678.00K |
| 2025-06-30 | Reported | (m) | $3.20M | (m) | $9.95M | (m) | $51.00K* | $2.87M* | $4.36M | $135.00K | $2.26M | $788.00K |
| 2025-03-31 | Reported | (m) | $3.15M | (m) | $9.71M | (m) | $184.00K | $4.46M | $4.17M | $154.00K | $2.23M | $817.00K |
| 2024-09-30 | Reported | (m) | $3.34M | (m) | $10.01M | (m) | $89.00K* | $3.86M* | $4.20M | $172.00K | $2.29M | $616.00K |
| 2024-06-30 | Reported | (m) | $3.44M | (m) | $10.40M | (m) | $110.00K* | $2.76M* | $4.15M | $255.00K | $2.56M | $758.00K |
| 2024-03-31 | Reported | (m) | $3.88M | (m) | $11.34M | (m) | $22.00K | $5.28M | $4.57M | $266.00K | $2.62M | $842.00K |
| 2023-09-30 | Reported | (m) | $3.97M | (m) | $12.51M | (m) | $186.00K* | $5.12M* | $5.15M | $138.00K | $3.25M | $846.00K |
| 2023-06-30 | Reported | (m) | $4.42M | (m) | $12.87M | (m) | $320.00K* | $4.91M* | $5.13M | $133.00K | $3.18M | $972.00K |
| 2023-03-31 | Reported | (m) | $4.44M | (m) | $12.52M | (m) | $43.00K | $6.92M | $4.68M | $144.00K | $3.26M | $905.00K |
| 2022-09-30 | Reported | (m) | $5.14M | (m) | $12.96M | (m) | $321.00K* | $5.59M* | $4.77M | $112.00K | $2.93M | $1.06M |
| 2022-06-30 | Reported | (m) | $5.06M | (m) | $13.43M | (m) | $213.00K* | $4.83M* | $5.28M | $135.00K | $2.96M | $1.10M |
| 2022-03-31 | Reported | (m) | $4.52M | (m) | $12.32M | (m) | $237.00K | $5.05M | $4.79M | $123.00K | $2.89M | $996.00K |
| 2021-09-30 | Reported | (m) | $5.10M | (m) | $12.57M | (m) | $77.00K* | $5.99M* | $4.50M | $127.00K | $2.85M | $951.00K |
| 2021-06-30 | Reported | (m) | $4.76M | (m) | $12.60M | (m) | $212.00K* | $4.69M* | $4.82M | $128.00K | $2.89M | $1.40M |
| 2021-03-31 | Reported | (m) | $3.89M | (m) | $10.96M | (m) | $10.00K | $5.53M | $4.02M | $130.00K | $2.93M | $874.00K |
| 2020-09-30 | Reported | (m) | $3.59M | (m) | $10.48M | (m) | $95.00K* | $5.01M* | $3.98M | $125.00K | $2.79M | $655.00K |
| 2020-06-30 | Reported | (m) | $1.98M | (m) | $8.79M | (m) | $257.00K* | $3.68M* | $3.84M | $116.00K | $2.86M | $664.00K |
| 2020-03-31 | Reported | (m) | $3.86M | (m) | $10.90M | (m) | $454.00K | $5.67M | $4.07M | $135.00K | $2.84M | $848.00K |
| 2019-09-30 | Reported | (m) | $4.37M | (m) | $12.49M | (m) | $122.00K* | $6.37M* | $5.12M | $130.00K | $2.88M | $742.00K |
| 2019-06-30 | Reported | (m) | $4.48M | (m) | $11.85M | (m) | $118.00K* | $1.68M* | $4.35M | $113.00K | $2.91M | $1.04M |
| 2019-03-31 | Reported | (m) | $4.10M | (m) | $10.73M | (m) | $12.00K | $3.36M | $3.96M | $115.00K | $2.56M | $998.00K |
| 2018-09-30 | Reported | (m) | $4.40M | (m) | $10.39M | (m) | $54.00K* | $4.60M* | $4.10M | $108.00K | $1.78M | -$2.28M |
| 2018-06-30 | Reported | (m) | $5.06M | (m) | $10.96M | (m) | $28.00K* | $3.98M* | $3.98M | $117.00K | $1.81M | $1.25M |
| 2018-03-31 | Reported | (m) | $4.97M | (m) | $10.89M | (m) | $173.00K | $3.77M | $3.96M | $113.00K | $1.84M | $916.00K |
| 2017-09-30 | Reported | (m) | $4.68M | (m) | $10.13M | (m) | $60.00K* | $4.58M* | $3.63M | $103.00K | $1.71M | $1.07M |
| 2017-06-30 | Reported | (m) | $5.03M | (m) | $10.83M | (m) | $49.00K* | $3.44M* | (m) | $119.00K | $1.74M | $1.19M |
| 2017-03-31 | Reported | (m) | $4.72M | (m) | $10.26M | (m) | $65.00K | $4.31M | (m) | $118.00K | $1.69M | $1.22M |
| 2016-09-30 | Reported | (m) | $3.94M | (m) | (m) | (m) | $147.00K* | $3.38M* | (m) | $135.00K | $1.70M | $1.04M |
| 2016-06-30 | Reported | (m) | $4.32M | (m) | (m) | (m) | $42.00K* | $3.61M* | (m) | $119.00K | $1.82M | $1.12M |
| 2016-03-31 | Reported | (m) | $4.31M | (m) | (m) | (m) | $48.00K | $4.15M | (m) | $110.00K | $1.80M | $1.20M |
| 2015-09-30 | Reported | (m) | $4.00M | (m) | (m) | (m) | $42.00K* | $4.16M* | (m) | $110.00K | $1.97M | $1.08M |
| 2015-06-30 | Reported | (m) | $3.97M | (m) | (m) | (m) | $41.00K* | $3.49M* | (m) | $140.00K | $1.99M | $1.01M |
| 2015-03-31 | Reported | (m) | $3.88M | (m) | (m) | (m) | $68.00K | $2.24M | (m) | $156.00K | $2.08M | $1.00M |
| 2014-09-30 | Reported | (m) | $4.00M | (m) | (m) | (m) | $117.00K* | $5.10M* | (m) | $115.00K | $2.08M | $1.07M |
| 2014-06-30 | Reported | (m) | $4.06M | (m) | (m) | (m) | $178.00K* | $3.84M* | (m) | $115.00K | $2.17M | $1.10M |
| 2014-03-31 | Reported | (m) | $3.84M | (m) | (m) | (m) | $658.00K | $1.92M | (m) | $123.00K | $2.08M | $1.06M |
| 2013-09-30 | Reported | (m) | $3.67M | (m) | (m) | (m) | $111.00K* | $4.02M* | (m) | $126.00K | $2.16M | $1.01M |
| 2013-06-30 | Reported | (m) | $3.71M | (m) | (m) | (m) | $59.00K* | $2.32M* | (m) | $120.00K | $2.21M | $994.00K |
| 2013-03-31 | Reported | (m) | $3.89M | (m) | (m) | (m) | $52.00K | $2.72M | (m) | $123.00K | $2.27M | $1.05M |
| 2012-09-30 | Reported | (m) | $3.96M | (m) | (m) | (m) | $62.00K* | $3.96M* | (m) | $140.00K | $2.38M | $1.13M |
| 2012-06-30 | Reported | (m) | $3.55M | (m) | (m) | (m) | $72.00K* | $3.10M* | (m) | $147.00K | $2.37M | $1.03M |
| 2012-03-31 | Reported | (m) | $4.12M | (m) | (m) | (m) | $61.00K | $3.43M | (m) | $146.00K | $2.48M | $1.15M |
| 2011-09-30 | Reported | (m) | $3.54M | (m) | (m) | (m) | $38.00K* | $3.41M* | (m) | $138.00K | $2.84M | $1.04M |
| 2011-06-30 | Reported | (m) | $3.23M | (m) | (m) | (m) | $139.00K* | $1.68M* | (m) | $148.00K | $2.88M | $970.00K |
| 2011-03-31 | Reported | (m) | $2.16M | (m) | (m) | (m) | $19.00K | $2.76M | (m) | $101.00K | $1.45M | $806.00K |
| 2010-09-30 | Reported | (m) | $2.26M | (m) | (m) | (m) | -$656.00K* | $1.82M* | (m) | $101.00K | $977.00K | $777.00K |
| 2010-06-30 | Reported | (m) | $2.19M | (m) | (m) | (m) | (m) | (m) | (m) | $95.00K | $977.00K | $744.00K |
EBITDA 12 month
| Date | Basis | EBITDA | Operating income | Depreciation and amortization | Revenue | EBITDA margin | Capital spending | Operating cash flow | Cost of products and services | Research and development | Selling, general and administration | Income tax expense / benefit |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-12-31 | Reported | (m) | $11.40M | (m) | $38.52M | (m) | $371.00K | $14.69M | $16.52M | $668.00K | (m) | $2.82M |
| 2024-12-31 | Reported | (m) | $13.59M | (m) | $40.90M | (m) | $230.00K | $14.83M | $16.76M | $813.00K | (m) | $2.93M |
| 2023-12-31 | Reported | (m) | $16.78M | (m) | $50.22M | (m) | $639.00K | $22.28M | $20.19M | $560.00K | (m) | $3.45M |
| 2022-12-31 | Reported | (m) | $19.79M | (m) | $52.28M | (m) | $809.00K | $21.15M | $20.09M | $493.00K | (m) | $4.19M |
| 2021-12-31 | Reported | (m) | $18.88M | (m) | $49.05M | (m) | $552.00K | $21.20M | $18.14M | $526.00K | (m) | $4.27M |
| 2020-12-31 | Reported | (m) | $13.71M | (m) | $42.18M | (m) | $860.00K | $20.14M | $16.63M | $486.00K | (m) | $3.04M |
| 2019-12-31 | Reported | (m) | $17.63M | (m) | $46.90M | (m) | $540.00K | $17.06M | $17.44M | $483.00K | (m) | $3.16M |
| 2018-12-31 | Reported | (m) | $18.70M | (m) | $42.00M | (m) | $402.00K | $16.83M | $15.69M | $454.00K | (m) | $904.00K |
| 2017-12-31 | Reported | (m) | $19.01M | (m) | $41.41M | (m) | $1.60M | $16.91M | $15.02M | $447.00K | (m) | $10.58M |
| 2016-12-31 | Reported | (m) | $16.19M | (m) | $39.30M | (m) | $3.29M | $14.53M | $15.61M | $475.00K | (m) | $4.29M |
| 2015-12-31 | Reported | (m) | $15.65M | (m) | (m) | (m) | $176.00K | $13.80M | (m) | $522.00K | (m) | $3.70M |
| 2014-12-31 | Reported | (m) | $16.20M | (m) | (m) | (m) | $1.11M | $15.39M | (m) | $460.00K | (m) | $4.43M |
| 2013-12-31 | Reported | (m) | $14.83M | (m) | (m) | (m) | $339.00K | $12.31M | (m) | $491.00K | (m) | $3.07M |
| 2012-12-31 | Reported | (m) | $15.20M | (m) | (m) | (m) | $254.00K | $13.56M | (m) | $563.00K | (m) | $4.37M |
| 2011-12-31 | Reported | (m) | $11.84M | (m) | (m) | (m) | $247.00K | $11.37M | (m) | -$518.00K | (m) | $3.67M |
| 2010-12-31 | Reported | (m) | $8.92M | (m) | (m) | (m) | $1.53M | $7.16M | (m) | $397.00K | (m) | $3.03M |
| 2009-12-31 | Reported | (m) | $9.43M | (m) | (m) | (m) | $466.00K | $7.23M | (m) | $361.00K | (m) | $3.32M |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |
| Profound Medical Corp. (PROF) | $0.206B | -7.37 | |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |